{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:05:38Z","timestamp":1776863138203,"version":"3.51.2"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["smoa.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Up to 75% of women with ovarian cancer experience psychosexual morbidity and approximately 15\u201320% of women with ovarian cancer have a germline BRCA1\/2 mutation (gBRCAm). However, psychosexual morbidity remains unexplored in women with gBRCAm ovarian cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>Given their younger age, genetic diagnosis, breast cancer risk, and increased prevalence of surgically-induced menopause, we aim to assess whether women with gBRCAm ovarian cancer experience distinct psychosexual morbidity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Psychosexual morbidity was investigated in 2 cohorts of women with ovarian cancer: women with gBRCAm ovarian cancer vs women with gBRCA wildtype (gBRCAwt) ovarian cancer. Between August 2019 and March 2020, women with high-grade serous carcinoma of the ovary, Fallopian tube or primary peritoneum were approached in clinic or telephoned and invited to take part. Exclusion criteria included: women with alternative histology; women admitted from clinic; and women who lacked capacity to independently complete the questionnaire. The Female Sexual Function Index (FSFI) and background information were collected at a single time-point per patient. Scores below 26.55 were interpreted to suggest psychosexual dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Responses including total and domain FSFI scores, self-reported psychosexual problems and interest in psychosexual support were compared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 103 women approached, 53% returned questionnaires. In this exploratory analysis, women with gBRCAm ovarian cancer were significantly younger (51\u201360 years vs 61\u201370 years, gBRCAwt, P\u00a0=\u00a0.010). There was a trend towards increased prevalence of surgical menopause (57% vs 27%, P\u00a0=\u00a0.097) and breast surgery (53% vs 22%, P\u00a0=\u00a0.132, gBRCAm vs gBRCAwt, respectively). Women with gBRCAm ovarian cancer scored higher in the FSFI questionnaire, particularly women under 60 years (15.1 vs 2.7, P\u00a0=\u00a0.070), approaching significance. Women with gBRCAm ovarian cancer expressed more interest for face-to-face services (P\u00a0=\u00a0.018), especially psychosexual therapy (65% vs 30%) and more often felt the service was insufficient, approaching significance (71% vs 44%, gBRCAm vs gBRCAwt, respectively, P\u00a0=\u00a0.076).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Women with gBRCAm ovarian cancer are younger, express more interest for specialist psychosexual support and potentially different psychosexual problems, warranting further exploration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.esxm.2021.100465","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T13:15:36Z","timestamp":1639574136000},"page":"100465-100465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status"],"prefix":"10.1093","volume":"10","author":[{"given":"Chloe A.","family":"Logue","sequence":"first","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Pugh","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Foden","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem D.","family":"Mahmood","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"},{"name":"The University of Manchester , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Morgan","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"},{"name":"The University of Manchester , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Mitchell","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"},{"name":"The University of Manchester , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurjees","family":"Hasan","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"},{"name":"The University of Manchester , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Clamp","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"},{"name":"The University of Manchester , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon C.","family":"Jayson","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust , Manchester , UK"},{"name":"The University of Manchester , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"2023012008294839700_bib1","author":"CRUK. Ovarian cancer statistics 2020, Available at:"},{"key":"2023012008294839700_bib2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"2023012008294839700_bib3","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1200\/JCO.2018.36.15_suppl.5575","article-title":"LION-PAW: Lymphadenectomy in ovarian neoplasm-pleasure ability of women\u2014Prospective substudy of the randomized multicenter LION study","author":"Hasenburg","year":"2018","journal-title":"Am Soc Clin Oncol"},{"key":"2023012008294839700_bib4","article-title":"Ovarian cancer survivors: Qualitative analysis of the symptom of sexuality","volume":"38","author":"Wilmoth","year":"2011"},{"key":"2023012008294839700_bib5","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/ijgc-2020-002001","article-title":"Psychosexual morbidity in women with ovarian cancer","volume":"30","author":"Logue","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"2023012008294839700_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.esxm.2019.07.005","article-title":"Sexual function, quality of life, and experiences of women with ovarian cancer: A mixed-methods study","volume":"7","author":"Fischer","year":"2019","journal-title":"Sex Med"},{"key":"2023012008294839700_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ygyno.2019.04.397","article-title":"Risk for anxiety and depression among individuals with ovarian cancer: The interplay between age and distress","volume":"154","author":"Donziger","year":"2019","journal-title":"Gynecol Oncol"},{"key":"2023012008294839700_bib8","author":"NHSE. Living with and beyond cancer: NHS England; 2016 Available at:"},{"key":"2023012008294839700_bib9","author":"Ovarian cancer: Recognition and initial management National Institute for Health and Care Excellence (NICE): NICE; 2011 Available a:"},{"key":"2023012008294839700_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2016.04.429","article-title":"Symptom management in women with recurrent ovarian cancer: Do patients and providers agree on what symptoms are most important?","volume":"141","author":"Hay","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2023012008294839700_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ajog.2017.04.012","article-title":"Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer","volume":"217","author":"Whicker","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2023012008294839700_bib12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0959-8049(03)00307-1","article-title":"An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer","volume":"39","author":"Greimel","year":"2003","journal-title":"Eur J Cancer"},{"key":"2023012008294839700_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"2023012008294839700_bib14","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1002\/cncr.26739","article-title":"Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors","volume":"118","author":"Baser","year":"2012","journal-title":"Cancer"},{"key":"2023012008294839700_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/B978-0-444-63247-0.00002-X","article-title":"Human sexual response","volume":"130","author":"Basson","year":"2015","journal-title":"Handbook of Clinical Neurology"},{"key":"2023012008294839700_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/ijerph17030994","article-title":"The female sexual function index: Transculturally adaptation and psychometric validation in Spanish women","volume":"17","author":"S\u00e1nchez-S\u00e1nchez","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2023012008294839700_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsxm.2019.10.007","article-title":"Scoring and Interpretation of the FSFI: What can be learned from 20 years of use?","volume":"17","author":"Meston","year":"2020","journal-title":"J Sex Med"},{"key":"2023012008294839700_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ijgo.12623","article-title":"Psychosexual health in gynecologic cancer","volume":"143","author":"Boa","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"2023012008294839700_bib19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11136-015-1181-6","article-title":"Quality of life among patients after bilateral prophylactic mastectomy: A systematic review of patient-reported outcomes","volume":"25","author":"Razdan","year":"2016","journal-title":"Qual Life Res"},{"key":"2023012008294839700_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/02841868909111174","article-title":"Long-term psychological sequelae of mastectomy and breast conserving treatment for breast cancer","volume":"28","author":"Meyer","year":"1989","journal-title":"Acta Oncol (Madr)"},{"key":"2023012008294839700_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejon.2014.03.007","article-title":"Maximising survival: The main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1\/2","volume":"18","author":"Jeffers","year":"2014","journal-title":"Eur J Oncol Nurs"},{"key":"2023012008294839700_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1037\/a0014778","article-title":"Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review","volume":"28","author":"Hamilton","year":"2009","journal-title":"Health Psychol"},{"key":"2023012008294839700_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00435972","article-title":"The sexual activity questionnaire: A measure of women's sexual functioning","volume":"5","author":"Thirlaway","year":"1996","journal-title":"Qual Life Res"},{"key":"2023012008294839700_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale: An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116121001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116121001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/10\/1\/100465\/48792585\/smoa_10_1_100465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/10\/1\/100465\/48792585\/smoa_10_1_100465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T08:34:51Z","timestamp":1674203691000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/10\/1\/100465\/6956789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.esxm.2021.100465","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2]]},"published":{"date-parts":[[2021,12,15]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esxm.2021.100465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}